Register

Forgot your password?

Forgot your username?

Cellmid Limited

Suite 1802, Level 18 15 Castlereagh Street
Sydney, NSW 2000 Australia
phone:phone
fax:fax
Click for website
Research Sector Diagnostics & Therapeutics
Summary Description Cellmid Limited (ASX:CDY) is a biotechnology company listed on the Australian Stock Exchange. The company is developing innovative therapies and diagnostic tests for heart attack, inflammatory diseases and cancer. Cellmid holds the largest and most comprehensive portfolio of intellectual property related to midkine, an extensively validated therapeutic and diagnostic target in inflammation, autoimmunity and cancer. Cellmid is actively looking for partners to commercialise these significant midkine intellectual property assets in ischemia, cancer and inflammatory diseases.

Click here for Financial Data Keywordscancer, oncology, inflammation, therapy, therapeutic

Description

Cellmid Limited (ASX:CDY) is a biotechnology company listed on the Australian Stock Exchange. The company is developing innovative therapies and diagnostic tests for heart attack, inflammatory disease......view more

Products / Services

MidKine Kit......view more


Technology / Differentiation

Discovered in 1988 by Professors Takashi Muramatsu and Kenji Kadomatsu, MK is a multifunctional growth factor that is highly expressed during embryonic development. Midkine modulates many important bi...view more

RELATED COMPANIES




Deprecated: mysql_connect(): The mysql extension is deprecated and will be removed in the future: use mysqli or PDO instead in /home/onemedpl/public_html/include/counter.php on line 10